The Global AI in Oncology Market is to Hit USD 5.56 billion in 2030 at a Growth rate of 12.35% as per Stellar Market Research study

Stellar Market Research, a Healthcare business research firm has published a report on the "AI in Oncology Market". The total market opportunity for AI in Oncology was USD 2.46 billion in 2023 and is expected to grow at 12.35% CAGR through the forecast period by reaching nearly USD 5.56 billion.

For in-depth information on this study, visit the following link:https://www.stellarmr.com/report/req_sample/ai-in-oncology-market/2410

AI in Oncology Market Report Scope and Research Methodology

Market Size in 2023: USD 2.46 billion

Market Size in 2030: USD 5.56 billion

CAGR: 12.35%

Forecast Period: 2024-2030

Base Year: 2023

Number of Pages: 247

No. of Tables: 52

No. of Charts and Figures: 47

Segment Covered: By Component, Cancer Type, Application, End User, and Region.

Report Coverage: Market Share, Size and Forecast by Revenue 2023-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, Key Trends, Competitive Landscape, Competitive Analysis, MMR Competition Matrix, Key Players Benchmarking, Competitive Leadership Mapping, Global Key Players Market Ranking Analysis.

AI in Oncology Market Overview:

The AI in oncology market is advancing rapidly with predictive analytics, multi-omics integration, and robotic surgery enhancing treatment precision and personalization. Key players like Tempus and Foundation Medicine are driving growth, while Roche's lab automation and iRhythm Technologies' wearable tech improve diagnostics and monitoring. Despite challenges in AI model interpretability, breast cancer dominates market revenue, with prostate cancer showing high growth potential. North America leads due to strong infrastructure, while Asia Pacific is poised for significant growth.

AI in Oncology Market Dynamics:

AI is revolutionizing personalized oncology with predictive analytics and multi-omics integration, enhancing treatment precision and patient outcomes. In the US, companies like Tempus and Foundation Medicine are leading this shift. AI-driven robotic systems, such as the Da Vinci Surgical System, are improving surgical precision in Europe, especially the UK, while automation, like Roche's Lab Automation Solutions, enhances efficiency. However, challenges like AI's "black box" nature hinder clinical adoption due to the need for transparency and interpretability.

For in-depth information on this study, visit the following link:https://www.stellarmr.com/report/req_sample/ai-in-oncology-market/2410

AI in Oncology Market Segment Analysis:

By Component

Software Solutions
Hardware
Services

By Cancer Type

Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others

By Application

Diagnostics
Radiation Therapy
Research & Development
Chemotherapy
Immunotherapy

By End User

Surgical Centers and Medical Institutes
Hospitals
Others

Key Players in the AI in Oncology Market

Azra AI
IBM
Siemens Healthcare GmbH
Intel Corporation
GE HealthCare
NVIDIA Corporation
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI

Key questions answered in the AI in Oncology Market report are:

What are the driving factors and opportunities in the AI in Oncology Market?
What are the major trends that would shape the future Global AI in Oncology Market?
What is the Expected growth of the Global AI in Oncology Market size from 2023 to 2030?
What is the growth rate of the Global AI in Oncology Market during the forecast period?
What are the leading market players in the Global AI in Oncology Market?

To access more details regarding this research, visit the following webpage:https://www.stellarmr.com/report/ai-in-oncology-market/2410

Key Offerings:

Historical Market Size and Competitive Landscape
Market Size, Share, Size & Forecast by Different Segments| 2023-2030
AI in Oncology Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends
AI in Oncology Market Segmentation- A detailed analysis by Type, End-user, and Region
Competitive Landscape- Profiles of selected key players by region in a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis

Stellar Market Research is leading Healthcare Research Firm, has also published the following reports:

The Augmented Bone Graft Market size was valued at USD 2.49 Bn. in 2023 and the total Augmented Bone Graft Market size is expected to grow at a CAGR of 6.97 % from 2024 to 2030, reaching nearly USD 3.99 Bn. by 2030. The market however faces growth challenges due to the high cost of surgeries and ethical issues associated with bone grafting procedures, notwithstanding these advancements.

Contact Stellar Market Research:

STELLAR MARKET RESEARCH PVT. LTD.

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud, Pune,

Pune, Maharashtra, 411029

mailto:sales@stellarmr.com

About Stellar Market Research:

Stellar Market Research is a consulting and advisory firm focused on helping clients reach their business transformation objectives with advisory services and strategic business. The company's vision is to be an integral part of the client's business as a strategic knowledge partner. Stellar Market Research provides end-to-end solutions that go beyond key research technologies to help executives in any organization achieve their mission-critical goals. The company uses its extensive industry knowledge, strong network, and know-how to provide complete insights that give clients a competitive advantage. Its strong emphasis on symptomatic science and analysis of a market, buyer behavior, product usage, pricing pattern, and industry facet equips a strategy maker with an arsenal of data that will enable their organization to maintain its stronghold or plan strategies and take actions that will result in remarkable growth and increase their market position.

This release was published on openPR.